Class information for:
Level 1: TAMOXIFEN//TOREMIFENE//DROLOXIFENE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
5027 1617 37.6 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
232 19686 TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TAMOXIFEN Author keyword 86 14% 35% 572
2 TOREMIFENE Author keyword 77 55% 6% 97
3 DROLOXIFENE Author keyword 13 46% 1% 21
4 GYNECOL ULTRASOUND UNIT Address 6 58% 0% 7
5 EM 800 Author keyword 5 63% 0% 5
6 ANTIESTROGENS Author keyword 4 12% 2% 34
7 ENDOMETRIAL PATHOLOGIES Author keyword 3 50% 0% 5
8 EM 652 Author keyword 3 45% 0% 5
9 SCH 57068 Author keyword 3 60% 0% 3
10 CANCEROGENICITY Author keyword 2 67% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 TAMOXIFEN 86 14% 35% 572 Search TAMOXIFEN Search TAMOXIFEN
2 TOREMIFENE 77 55% 6% 97 Search TOREMIFENE Search TOREMIFENE
3 DROLOXIFENE 13 46% 1% 21 Search DROLOXIFENE Search DROLOXIFENE
4 EM 800 5 63% 0% 5 Search EM+800 Search EM+800
5 ANTIESTROGENS 4 12% 2% 34 Search ANTIESTROGENS Search ANTIESTROGENS
6 ENDOMETRIAL PATHOLOGIES 3 50% 0% 5 Search ENDOMETRIAL+PATHOLOGIES Search ENDOMETRIAL+PATHOLOGIES
7 EM 652 3 45% 0% 5 Search EM+652 Search EM+652
8 SCH 57068 3 60% 0% 3 Search SCH+57068 Search SCH+57068
9 CANCEROGENICITY 2 67% 0% 2 Search CANCEROGENICITY Search CANCEROGENICITY
10 ENDOMETRIAL HISTOPATHOLOGY 2 67% 0% 2 Search ENDOMETRIAL+HISTOPATHOLOGY Search ENDOMETRIAL+HISTOPATHOLOGY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PATIENTS RECEIVING TAMOXIFEN 125 75% 6% 89
2 ALPHA HYDROXYTAMOXIFEN 88 80% 3% 55
3 ADJUVANT TAMOXIFEN 65 27% 13% 210
4 REDUCED GENOTOXICITY 57 95% 1% 19
5 LIVER CARCINOGEN 49 94% 1% 17
6 TOREMIFENE 43 44% 5% 74
7 RECEIVING TAMOXIFEN 41 63% 3% 42
8 TRIPHENYLETHYLENE COMPOUND 36 71% 2% 29
9 ACETOXYTAMOXIFEN 30 100% 1% 12
10 HIGH DOSE TOREMIFENE 30 84% 1% 16

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Endometrial pathologies associated with postmenopausal tamoxifen treatment 2004 102 86 93%
Tamoxifen: A most unlikely pioneering medicine 2003 238 36 44%
Basic guide to the mechanisms of antiestrogen action 1998 477 441 30%
Tamoxifen treatment and gynecologic side effects: A review 2001 102 98 65%
Is tamoxifen a genotoxic carcinogen in women? 2009 17 141 77%
Selective estrogen receptor modulators: Clinical spectrum 1999 165 135 53%
Toremifene for Breast Cancer: A Review of 20 Years of Data 2014 4 47 45%
The effects of tamoxifen on the female genital tract 2004 36 60 85%
Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials 2011 17 21 48%
Toremifene: An evaluation of its safety profile 2006 33 122 65%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 GYNECOL ULTRASOUND UNIT 6 58% 0.4% 7
2 CANCBREAST CANC DIS PROGRAMDANA FARBER HARV 1 100% 0.1% 2
3 CARCINOGEN DNA INTERACT SECT 1 14% 0.4% 7
4 EARLY DETECT COMMUNITY ONCOL PROGRAM 1 40% 0.1% 2
5 LYNN SAGE BREAST CANC PROGRAM 1 25% 0.2% 3
6 ST LUCS HOSP 1 33% 0.1% 2
7 ANTIDOPING ROME 1 50% 0.1% 1
8 BAGHIATOLLAH HOSP 1 50% 0.1% 1
9 CLERMONT FERRAND MED 1 50% 0.1% 1
10 CLIN BREAST DIS 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000247765 RALOXIFENE//TISSUE SELECTIVE ESTROGEN COMPLEX//BAZEDOXIFENE
2 0.0000236454 ENDOXIFEN//DESMETHYLTAMOXIFEN//N DESMETHYL TAMOXIFEN
3 0.0000211021 AEBS//ANTIESTROGEN BINDING SITES//ANALOG II
4 0.0000133525 ESTROGENIC RECRUITMENT//AMINOGLUTETHIMIDE//CYCLIC TREATMENT
5 0.0000117572 AROMATASE INHIBITORS//EXEMESTANE//ANASTROZOLE
6 0.0000102459 POSTMENOPAUSAL BLEEDING//HYSTEROSCOPY//ENDOMETRIAL POLYPS
7 0.0000083060 ESTROGEN RECEPTOR VARIANTS//JC HEUSON CANCEROL MAMMAIRE//SERV HISTOL CYTOL EXPT
8 0.0000080155 SERAMS//MATH CHEM//ESTROGEN RECEPTOR LIGANDS
9 0.0000078659 SUBJEFATURA INVEST BIOMED//UNIDAD INVEST MED BIOL REPROD//COLPOSCOPIA
10 0.0000070095 HS OS 1//BRM BIOLOGICAL RESPONSE MODIFIER//DIAGNOST RADIOL RADIAT ONCOL